On May 2, 2022, Abbott Laboratories announced that at its annual general meeting of shareholder held on April 29, 2022, the shareholders rejected a shareholder proposal to lower the ownership threshold for calling special meetings of shareholders.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.6 USD | +0.02% | +0.61% | -2.14% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
26/04 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.14% | 187B | |
-1.70% | 106B | |
-3.93% | 66.9B | |
+0.16% | 49.45B | |
+16.33% | 48B | |
+4.06% | 40.84B | |
+3.44% | 26.48B | |
+1.18% | 26.25B | |
+12.96% | 24.62B | |
-0.58% | 24.52B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Declaration of Voting Results by Abbott Laboratories